Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
163
datasets available to search
ShareScore release 0.9.0
Dataset results
163 results for “coronavirus disease 2019”
Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04409509. IPD Sharing: YES. Countries: 1. Publications: 1.
Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients
ClinicalTrials.gov study NCT04524507. IPD Sharing: YES. Countries: 1. Publications: 1.
The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04389671. IPD Sharing: NO. Countries: 2. Publications: 2.
Looking in the medicine cabinet: methods for using real-world data to assess the impact of measles, mumps and rubella (MMR) and recombinant adjuvanted varicella-zoster vaccines on coronavirus disease 2019 (COVID-19) prevention and case fatality
<p>Supplementary File S1. 20210712_vx_off_target_pubdraft_S1 (Tables, Graphs and scripts associated with publication)</p> <p>Data file 1. Basic_Analysis.R (descriptive analysis script in R, for use with cleaned data files 3, 4 and 6)<br> Data file 2. Cleaning (Script demonstrating how Cerner data was cleaned upon download)<br> Data file 3. COVID_all_cleaned (CSV file with all COVID+ subjects in Cerner institutions)<br> Data file 4. COVID_mmr_data_cleaned (CSV file with COVID+ patients between 25-64 years old, including institution id, age category, gender, whether patient is in emergency department or inpatient, flu vaccine history, MMR vaccine history and mortality outcomes)<br> Data file 5. COVID_mmr_data_matched (CSV file matching MMR vaccine-exposed cases to controls based on propensity scores)<br> Data file 6. COVID_zoster_data_cleaned (CSV file with COVID+ patients above 50 years old, including institution id, age category, gender, whether patient is in emergency department or inpatient, flu vaccine history, zoster vaccine history and mortality outcomes)<br> Data file 7. COVID_zoster_data_matched (CSV file matching zoster vaccine-exposed cases to controls based on propensity scores)<br> Data file 8. General_25_64_data_cleaned (CSV file, all patients in Cerner institutions between 25 – 64 years old, including institution id, age category, gender, whether patient is in emergency department or inpatient, flu vaccine history, MMR vaccine history, SARS-CoV-2 infection and COVID-19 mortality outcomes ).<br> Data file 9. General_over50_data_cleaned (CSV file, all patients in Cerner institutions above 50 years old, including institution id, age category, gender, whether patient is in emergency department or inpatient, flu vaccine history, zoster vaccine history, SARS-CoV-2 infection and COVID-19 mortality outcomes).<br> Data file 10. Included_tenants (CSV file, institution IDs whose contributed cases comprise at least 0.5% of the aggregate sample size).<br> Data file 11. MMR_ps (R script to run for MMR-related files analysis)<br> Data file 12. Zoster_ps (R script to run for zoster-related files analysis)</p>
Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to Coronavirus Disease 2019
ClinicalTrials.gov study NCT04659876. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019
ClinicalTrials.gov study NCT04338009. IPD Sharing: NO. Countries: 1. Publications: 36.
Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04745351. IPD Sharing: YES. Countries: 6. Publications: 2.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04551898. IPD Sharing: YES. Countries: 4. Publications: 2.
A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID
ClinicalTrials.gov study NCT04508023. IPD Sharing: YES. Countries: 1. Publications: 2.
Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019
ClinicalTrials.gov study NCT04883528. IPD Sharing: NO. Countries: 1. Publications: 1.
Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).
ClinicalTrials.gov study NCT04898166. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use
ClinicalTrials.gov study NCT05191446. IPD Sharing: YES. Countries: 1. Publications: 6.
Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04341116. IPD Sharing: NO. Countries: 1. Publications: 1.
Transmission of Coronavirus Disease 2019 (COVID19) in Crowded Environments
ClinicalTrials.gov study NCT05119348. IPD Sharing: NO. Countries: 1. Publications: 1.
Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019)
ClinicalTrials.gov study NCT04359654. IPD Sharing: NO. Countries: 1. Publications: 1.
Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma
ClinicalTrials.gov study NCT04502472. IPD Sharing: NO. Countries: 1. Publications: 15.
Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting
ClinicalTrials.gov study NCT04501952. IPD Sharing: YES. Countries: 4. Publications: 4.
Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity
ClinicalTrials.gov study NCT04747366. IPD Sharing: NO. Countries: 1. Publications: 3.
A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04701658. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)
ClinicalTrials.gov study NCT04939428. IPD Sharing: YES. Countries: 23. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.